190 related articles for article (PubMed ID: 36715827)
1. Radiosynthesis and preclinical evaluation of [
Cools R; Vermeulen K; Narykina V; Leitao RCF; Bormans G
EJNMMI Radiopharm Chem; 2023 Jan; 8(1):2. PubMed ID: 36715827
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of [
Vermeulen K; Naus E; Ahamed M; Attili B; Siemons M; Luyten K; Celen S; Schymkowitz J; Rousseau F; Bormans G
Theranostics; 2019; 9(2):554-572. PubMed ID: 30809293
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Evaluation of [
Vermeulen K; Cools R; Briard E; Auberson Y; Schoepfer J; Koole M; Cawthorne C; Bormans G
ACS Chem Neurosci; 2021 Oct; 12(20):3915-3927. PubMed ID: 34597516
[TBL] [Abstract][Full Text] [Related]
4. Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases.
Ernst JT; Liu M; Zuccola H; Neubert T; Beaumont K; Turnbull A; Kallel A; Vought B; Stamos D
Bioorg Med Chem Lett; 2014 Jan; 24(1):204-8. PubMed ID: 24332488
[TBL] [Abstract][Full Text] [Related]
5. Following the design path of isoform-selective Hsp90 inhibitors: Small differences, great opportunities.
Dernovšek J; Tomašič T
Pharmacol Ther; 2023 May; 245():108396. PubMed ID: 37001734
[TBL] [Abstract][Full Text] [Related]
6. Cytosolic Hsp90α and its mitochondrial isoform Trap1 are differentially required in a breast cancer model.
Vartholomaiou E; Madon-Simon M; Hagmann S; Mühlebach G; Wurst W; Floss T; Picard D
Oncotarget; 2017 Mar; 8(11):17428-17442. PubMed ID: 28407697
[TBL] [Abstract][Full Text] [Related]
7. Cytosolic Hsp90 Isoform-Specific Functions and Clinical Significance.
Maiti S; Picard D
Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139005
[TBL] [Abstract][Full Text] [Related]
8. The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep.
Chang C; Tang X; Woodley DT; Chen M; Li W
Cells; 2023 Jan; 12(2):. PubMed ID: 36672211
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of HSP90 isoforms and their correlations with clinicopathologic factors in patients with colorectal cancer.
Kim K; Lee HW; Lee EH; Park MI; Lee JS; Kim MS; Kim K; Roh MS; Pak MG; Oh JE; Kim KM; Lee JW; Kim TG; Nam HY
Int J Clin Exp Pathol; 2019; 12(3):978-986. PubMed ID: 31933908
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel HSP90α/β isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating CNS disorders such as Huntington's disease.
Ernst JT; Neubert T; Liu M; Sperry S; Zuccola H; Turnbull A; Fleck B; Kargo W; Woody L; Chiang P; Tran D; Chen W; Snyder P; Alcacio T; Nezami A; Reynolds J; Alvi K; Goulet L; Stamos D
J Med Chem; 2014 Apr; 57(8):3382-400. PubMed ID: 24673104
[TBL] [Abstract][Full Text] [Related]
11. Chaperone Activity and Dimerization Properties of Hsp90
Morishima Y; Mehta RK; Yoshimura M; Lau M; Southworth DR; Lawrence TS; Pratt WB; Nyati MK; Osawa Y
Mol Pharmacol; 2018 Sep; 94(3):984-991. PubMed ID: 29941666
[TBL] [Abstract][Full Text] [Related]
12. Expressed as the sole Hsp90 of yeast, the alpha and beta isoforms of human Hsp90 differ with regard to their capacities for activation of certain client proteins, whereas only Hsp90beta generates sensitivity to the Hsp90 inhibitor radicicol.
Millson SH; Truman AW; Rácz A; Hu B; Panaretou B; Nuttall J; Mollapour M; Söti C; Piper PW
FEBS J; 2007 Sep; 274(17):4453-63. PubMed ID: 17681020
[TBL] [Abstract][Full Text] [Related]
13. Identification of Isoform-Selective Ligands for the Middle Domain of Heat Shock Protein 90 (Hsp90).
Mak OW; Chand R; Reynisson J; Leung IKH
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717777
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the middle domains stabilizes Hsp90α dimer in a closed conformation with high affinity for p23.
Synoradzki K; Miszta P; Kazlauskas E; Mickevičiūtė A; Michailovienė V; Matulis D; Filipek S; Bieganowski P
Biol Chem; 2018 Mar; 399(4):337-345. PubMed ID: 29337688
[TBL] [Abstract][Full Text] [Related]
15. Proliferation, migration, and resistance to oxidative and thermal stresses of HT1080 cells with knocked out genes encoding Hsp90α and Hsp90β.
Petrenko V; Vrublevskaya V; Bystrova M; Masulis I; Kopylova E; Skarga Y; Zhmurina M; Morenkov O
Biochem Biophys Res Commun; 2023 Sep; 674():62-68. PubMed ID: 37406487
[TBL] [Abstract][Full Text] [Related]
16. GCUNC45 is the first Hsp90 co-chaperone to show alpha/beta isoform specificity.
Chadli A; Felts SJ; Toft DO
J Biol Chem; 2008 Apr; 283(15):9509-12. PubMed ID: 18285346
[TBL] [Abstract][Full Text] [Related]
17. Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants.
Prince TL; Kijima T; Tatokoro M; Lee S; Tsutsumi S; Yim K; Rivas C; Alarcon S; Schwartz H; Khamit-Kush K; Scroggins BT; Beebe K; Trepel JB; Neckers L
PLoS One; 2015; 10(10):e0141786. PubMed ID: 26517842
[TBL] [Abstract][Full Text] [Related]
18. Selective Inhibition of the Hsp90α Isoform.
Mishra SJ; Khandelwal A; Banerjee M; Balch M; Peng S; Davis RE; Merfeld T; Munthali V; Deng J; Matts RL; Blagg BSJ
Angew Chem Int Ed Engl; 2021 May; 60(19):10547-10551. PubMed ID: 33621416
[TBL] [Abstract][Full Text] [Related]
19. NECA derivatives exploit the paralog-specific properties of the site 3 side pocket of Grp94, the endoplasmic reticulum Hsp90.
Huck JD; Que NLS; Immormino RM; Shrestha L; Taldone T; Chiosis G; Gewirth DT
J Biol Chem; 2019 Nov; 294(44):16010-16019. PubMed ID: 31501246
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of heat shock protein 90 isoforms in small cell lung cancer.
Lee JH; Kang KW; Kim JE; Hwang SW; Park JH; Kim SH; Ji JH; Kim TG; Nam HY; Roh MS; Lee EH; Park MI; Kim MS; Lee HW
Int J Clin Exp Pathol; 2015; 8(8):9487-93. PubMed ID: 26464709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
